Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ANKRD54	LIAR	ENSG00000100124	"Ankyrin repeat domain 54"	Q6NXT1	22	37830855-37849327	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071287	Approved		Approved	Nucleoplasm,Microtubules,Midbody				"Microtubules, Midbody"	Nucleoplasm	"HPA071287: "	"unprognostic (5.36e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.02e-1)"	"prognostic favourable (7.38e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.02e-3)"	7.8	14.8	18.4	7.9	15.8	7.5	9.1	20.0	19.5	13.5	11.9	14.1	17.4	9.8	11.2	14.9	13.6	33.5	11.4	8.9	17.1	20.6	13.0	11.9	9.3	8.1	14.2	12.1	19.0	24.6	15.3	16.4	7.9	14.8	13.1	9.4	13.4	19.1	16.3	9.3	11.8	9.5	13.5	11.7	7.5	8.9	23.7	11.0	12.3	18.2	8.7	9.8	11.6	13.9	6.2	6.7	3.5	10.0	12.8	6.9	3.8	10.8	11.1	9.3	13.7	12.6	7.1	5.0	15.1	11.7	25.7	15.8	7.0	4.3	10.6	6.3	9.9	9.8	11.9	8.4	12.5	8.4	24.1	5.2	10.0	16.6	11.3	10.5	12.7	6.4	8.7	13.9	8.1	15.7	6.9	7.4	11.7	11.4	10.1	12.0	2.7	10.1	11.9	11.4	6.6	14.1	3.6	16.3	8.7	12.6	11.2	17.9	11.5	16.6	9.1	14.9	16.1	7.8	11.0	8.3	6.6	8.4	12.4	8.9	10.8	2.6	5.4	2.4	6.8	6.4	6.8	4.5	6.6	5.2	6.7	6.2	6.9	3.4	3.5	12.8	10.0	6.7	2.8	3.8	18.4	15.8	20.0	19.5	17.1	20.6	14.2	12.1	14.8	11.0
APC2	APCL	ENSG00000115266	"APC2, WNT signaling pathway regulator"	O95996	19	1446302-1473244	"Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 59.4"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;SCLC-21H: 7.6;SH-SY5Y: 25.9"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"				"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: "	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	1.5	4.7	17.3	1.4	16.4	1.5	1.3	21.7	59.4	1.4	1.6	20.7	0.0	2.1	1.4	1.4	1.4	1.5	1.6	1.4	16.8	13.9	1.3	1.3	1.4	1.4	15.0	14.0	1.3	2.0	1.3	3.0	1.4	17.1	1.4	1.4	0.8	1.7	1.4	1.6	1.4	1.8	1.5	13.9	1.4	1.4	1.8	14.5	0.0	1.5	0.0	1.3	1.6	0.0	1.1	0.2	0.4	0.0	0.0	0.1	0.1	0.2	0.5	6.3	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.7	0.0	0.0	7.6	25.9	0.9	0.0	0.4	0.1	0.0	0.0	0.5	0.5	0.2	0.2	1.9	0.4	0.3	0.7	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	17.3	16.4	21.7	21.3	16.8	13.9	15.0	14.0	17.1	14.5
BCL3	"BCL4, D19S37"	ENSG00000069399	"B cell CLL/lymphoma 3"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.5;Karpas-707: 22.0;SiHa: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody				Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: "	"prognostic favourable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	17.7	13.0	4.0	21.1	5.6	35.2	18.7	1.4	4.7	11.7	14.9	2.4	5.9	24.5	10.4	9.7	27.1	12.5	22.7	20.1	3.9	2.0	17.8	52.1	36.4	20.5	4.3	0.5	26.5	13.2	2.4	9.2	9.5	5.6	16.0	8.0	8.8	13.7	13.7	20.2	9.0	35.5	11.5	6.5	41.6	15.0	8.3	4.0	6.5	13.9	22.9	37.0	18.7	11.9	1.3	2.6	16.5	2.4	1.8	1.5	0.7	3.8	13.4	0.3	7.1	2.6	5.4	0.6	2.4	2.6	1.5	2.2	2.8	7.1	3.8	5.5	4.7	4.3	0.9	4.0	0.9	26.5	0.2	0.4	7.0	3.6	6.2	0.3	11.4	9.4	3.2	3.3	4.2	4.0	0.5	22.0	0.9	3.2	0.0	2.9	0.3	5.6	1.7	2.7	1.4	6.8	8.1	0.0	0.4	28.2	14.4	0.7	5.0	2.9	6.7	4.8	5.0	7.5	0.9	20.9	8.2	3.9	8.9	0.5	3.6	0.2	2.4	4.2	0.7	1.6	1.0	1.3	0.9	1.1	2.1	1.1	0.5	0.6	16.5	1.8	0.9	2.6	1.5	0.7	4.0	5.6	1.4	4.7	3.9	2.0	4.3	0.5	5.6	4.0
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"				Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: , HPA059634: , HPA067060: "	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favourable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favourable (3.63e-4)"	12.3	19.9	16.8	16.4	23.8	17.3	10.1	14.8	21.9	11.1	18.3	8.1	16.4	23.4	12.1	21.7	14.4	14.4	19.4	8.7	15.3	12.6	22.2	33.9	11.8	14.0	13.3	19.4	11.3	22.2	21.6	27.7	13.6	15.8	13.6	12.6	8.1	17.2	8.9	17.5	14.1	20.7	9.0	10.7	15.9	19.0	8.7	13.6	8.0	27.1	10.1	12.1	10.8	14.5	7.8	14.5	3.4	15.3	15.2	13.3	8.8	14.5	9.5	7.7	3.1	3.2	6.1	8.0	12.0	6.8	8.6	2.9	7.3	11.1	12.9	6.2	10.4	10.2	3.3	16.8	5.4	2.8	8.0	5.1	10.6	0.8	13.2	8.2	9.3	7.4	5.6	5.4	8.2	15.0	13.3	1.7	9.8	19.0	9.9	23.5	15.6	7.2	14.4	10.4	18.1	15.4	11.6	7.5	16.3	15.1	7.0	3.5	16.5	13.0	13.2	5.9	15.1	6.1	8.2	6.6	3.6	4.0	8.9	14.2	8.3	3.2	11.7	3.4	12.9	15.3	10.9	6.8	11.4	8.9	14.5	7.8	13.3	10.9	1.5	15.2	11.2	10.0	8.8	8.8	16.8	23.8	14.8	21.9	15.3	12.6	13.3	19.4	15.8	13.6
CENPV	"CENP-V, p30, PRR6"	ENSG00000166582	"Centromere protein V"	Q7Z7K6	17	16342534-16353656	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 34.1;HEK 293: 28.0;NTERA-2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6;memory B-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA042529, HPA042616"	Enhanced		Approved	Nucleoplasm,Midbody,Cytosol				Nucleoplasm	"Midbody, Cytosol"	"HPA042529: AB_10793882, HPA042616: AB_10794050"	"unprognostic (7.64e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.60e-3)"	4.6	5.6	13.7	4.0	14.7	6.2	6.6	12.0	17.3	4.2	19.5	6.7	2.8	13.6	8.0	5.5	1.3	9.1	3.5	5.7	10.2	10.1	5.2	14.6	2.5	2.3	7.8	11.8	9.1	5.9	3.7	7.3	2.2	5.8	4.6	11.5	2.4	1.6	6.4	25.4	0.9	29.1	6.1	7.3	1.5	18.0	10.6	6.1	22.5	4.0	2.9	2.1	3.2	2.3	3.3	1.0	3.6	0.0	0.0	1.0	0.3	3.2	6.4	34.1	17.2	0.9	0.9	5.9	2.7	2.7	8.6	6.6	6.4	1.4	13.1	5.5	2.0	0.9	22.0	0.2	5.4	0.0	28.0	3.0	1.7	12.6	9.6	3.1	0.0	2.4	0.9	10.3	6.1	4.8	5.3	0.0	2.5	0.5	24.4	10.4	33.5	0.0	17.6	1.3	1.5	1.9	4.8	18.3	13.9	6.9	0.1	1.5	0.1	7.7	0.3	0.0	2.7	0.3	0.0	0.0	0.0	7.6	0.0	4.3	0.2	0.0	0.0	3.6	0.3	0.0	0.1	3.3	0.1	0.1	0.7	0.3	1.0	0.9	0.0	0.0	0.0	1.0	0.2	0.3	13.7	14.7	12.0	17.3	10.2	10.1	7.8	11.8	5.8	6.1
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496632-93529092	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9;testis: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023430	Approved		Supported	"Plasma membrane,Midbody,Centriolar satellite"				"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavourable (3.20e-9)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (0.00e+0)"	"prognostic favourable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	3.2	1.4	0.5	12.1	0.4	3.1	3.6	0.3	0.6	2.0	5.2	0.3	0.2	4.6	0.8	1.5	11.6	0.6	2.5	0.7	0.4	0.5	1.5	0.7	4.4	10.1	0.6	0.2	0.8	0.6	0.0	0.7	3.8	0.5	0.8	6.5	0.4	2.3	0.2	0.7	3.0	5.2	3.5	1.1	4.8	3.2	19.3	0.3	52.9	0.7	10.8	11.0	2.7	3.3	0.1	0.1	0.0	0.0	0.0	4.4	0.0	51.0	20.4	13.6	17.2	1.5	3.1	7.6	28.1	19.9	26.7	27.7	21.6	27.5	13.6	12.4	18.2	29.2	16.4	13.8	32.1	41.0	8.5	5.1	12.6	7.3	0.1	8.8	11.9	0.7	1.0	28.4	34.7	24.6	4.6	25.9	30.1	11.8	23.2	13.4	5.3	14.9	10.1	22.2	7.5	12.0	6.3	5.6	7.9	21.6	6.7	17.0	17.5	9.0	15.3	16.9	23.7	23.2	46.1	11.6	15.7	16.7	13.2	33.4	15.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.5	0.4	0.3	0.6	0.4	0.5	0.6	0.2	0.5	0.3
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282069	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol				"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	29.7	37.5	48.0	24.3	48.6	18.8	36.2	39.9	49.4	28.3	39.0	28.1	28.4	38.1	28.2	36.3	39.2	31.4	30.6	35.1	45.1	45.2	55.6	39.2	35.6	26.1	44.1	47.5	26.5	19.9	36.4	34.8	55.7	47.4	40.8	40.9	19.8	26.0	30.2	27.1	25.6	51.9	27.5	49.2	33.0	37.3	21.2	37.0	24.9	42.0	26.1	26.0	33.7	33.5	12.4	27.8	51.2	24.6	18.1	16.6	18.1	30.8	23.0	23.4	15.1	35.9	32.7	21.9	30.9	35.0	49.3	54.8	17.5	19.6	16.7	34.2	29.0	13.4	24.5	25.2	40.1	34.5	17.3	14.0	46.5	19.0	31.2	17.7	27.6	34.7	46.7	33.1	30.9	25.6	15.0	22.1	38.8	14.1	18.4	54.9	21.5	28.4	11.3	20.8	11.0	40.5	16.9	11.5	29.6	31.4	18.5	28.3	18.9	28.0	25.5	24.7	25.8	21.1	27.3	14.7	29.1	19.2	35.6	12.3	15.8	31.5	20.1	40.2	10.7	21.6	11.5	12.4	14.3	14.0	18.3	10.6	13.2	12.5	51.2	18.1	24.6	27.8	16.6	18.1	48.0	48.6	39.9	49.4	45.1	45.2	44.1	47.5	47.4	37.0
CYSRT1	"C9orf169, MGC59937"	ENSG00000197191	"Cysteine rich tail 1"		9	137224635-137226311	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	4	"esophagus: 33.4"	"Cell line enhanced"	"Detected in many"		"A-431: 9.8;CAPAN-2: 12.4;HaCaT: 13.8;HeLa: 12.2;MCF7: 19.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021883, HPA021886"	Approved		Approved	"Nuclear speckles,Vesicles,Midbody"				"Nuclear speckles"	"Vesicles, Midbody"	"HPA021883: AB_1853190, HPA021886: AB_1853192"	"unprognostic (1.35e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.31e-3)"	"unprognostic (6.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	0.7	0.4	1.0	0.7	0.9	0.2	0.8	0.7	1.7	1.4	0.7	0.7	0.7	0.3	0.7	0.7	33.4	1.0	0.7	0.7	1.4	1.3	1.4	0.7	0.7	0.7	0.8	0.7	0.7	0.7	0.3	3.5	0.7	0.7	1.1	0.0	0.7	2.2	0.7	0.7	8.1	0.7	0.7	0.7	0.7	0.8	2.2	0.7	0.7	1.3	0.7	5.3	0.7	2.1	0.9	0.6	0.9	3.0	0.9	0.3	0.1	9.8	1.2	1.0	2.1	0.0	0.0	2.7	0.3	0.3	0.3	0.1	0.7	12.4	0.7	0.7	0.2	13.8	0.3	3.1	0.0	1.3	1.0	0.2	12.2	6.5	0.7	0.1	0.6	0.3	1.5	0.4	0.1	0.1	0.4	2.1	0.8	19.1	0.4	0.7	0.5	1.5	1.5	1.3	1.7	0.4	0.7	0.3	1.0	2.0	1.8	0.5	3.9	0.2	0.5	0.8	0.5	1.8	0.3	1.2	0.9	0.7	0.7	0.5	0.8	0.9	0.2	0.2	0.3	1.7	0.1	0.9	0.3	0.2	0.6	0.8	0.2	0.3	0.7	0.9	3.0	0.4	0.2	0.1	1.0	0.9	0.7	1.7	1.4	1.3	0.8	0.7	0.7	0.7
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123973-62153163	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;NK-cell: 4.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.9;NK-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Midbody"				"Nucleoplasm, Nuclear bodies, Midbody"		"CAB013292: AB_2533405, HPA051339: , HPA070550: "	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.25e-4)"	"prognostic unfavourable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavourable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	5.1	5.0	6.9	9.2	8.2	23.8	7.7	19.3	13.6	6.9	6.5	5.7	2.8	9.5	5.7	11.7	22.2	5.3	4.7	4.1	5.9	5.0	3.9	3.8	5.0	14.1	6.9	7.9	5.3	5.4	6.0	3.1	5.7	6.9	4.2	5.3	4.9	10.6	4.6	6.7	9.8	7.5	4.9	5.1	7.5	6.4	12.3	6.4	36.1	8.5	8.5	13.2	5.9	8.6	0.2	0.0	2.9	0.3	4.0	0.5	0.0	26.9	25.8	19.6	16.7	2.6	3.1	10.5	16.9	7.4	15.8	10.1	13.6	18.3	25.0	14.0	5.8	26.4	19.4	10.2	12.4	22.1	13.5	16.3	25.4	11.0	1.0	18.7	23.3	1.6	2.2	15.2	8.8	9.5	17.2	20.8	8.7	21.9	30.1	15.3	21.1	12.6	28.3	24.7	18.8	4.5	13.6	15.0	16.2	17.0	11.1	10.5	17.3	6.8	10.6	15.6	19.9	22.3	18.0	11.2	17.1	28.0	8.7	12.4	18.7	2.9	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.2	4.0	0.1	0.0	0.0	0.0	6.9	8.2	19.3	13.6	5.9	5.0	6.9	7.9	6.9	6.4
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"				"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: "	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006219			Supported	Nucleoplasm,Midbody,Centrosome				"Nucleoplasm, Centrosome"	Midbody	"HPA006219: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	28.7	11.2	25.0	20.0	1.3	2.9	16.8	21.6	15.4	44.2	38.6	18.9	20.8	33.1	10.4	10.6	13.7	25.4	14.5	40.5	21.4	10.9	39.2	19.8	15.7	0.1	28.9	18.2	0.7	1.4	31.5	15.4	14.2	30.9	28.4	27.9	11.2	30.4	17.5	24.4	14.1	24.4	37.8	20.8	7.4	10.4	17.2	12.3	28.7	20.5	18.1	11.8	22.0	8.4	16.1	31.9	17.4	37.8	15.1	15.3	47.8	10.3	28.2	30.9	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol			4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.8	9.5	9.1	8.6	18.1	22.1	0.1	17.1	19.3	62.3	75.7	17.3	20.7	42.7	11.4	13.1	6.7	34.2	12.1	23.7	16.3	9.8	23.7	10.5	22.6	21.1	21.3	15.2	22.4	7.7	20.4	10.7	21.6	22.9	30.5	14.6	11.7	18.9	29.2	19.0	18.2	29.4	8.7	21.6	16.2	12.7	13.5	11.1	15.7	9.7	33.5	8.2	8.2	14.0	15.8	10.7	16.6	29.7	28.1	42.9	36.9	21.4	35.5	15.3	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560078-50731824	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;HeLa: 4.4;NTERA-2: 3.0;SCLC-21H: 15.4;SH-SY5Y: 3.7"	"Group enriched"	"Detected in many"	5	"glioma: 15.2;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"				"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	1.9	26.4	16.9	1.1	33.4	0.9	1.8	15.9	23.9	1.4	2.6	9.5	3.8	1.6	1.8	4.5	3.5	1.5	3.0	16.9	13.0	14.3	4.5	7.0	3.5	0.9	17.1	9.1	4.2	2.5	43.5	8.3	3.7	20.5	5.3	1.8	4.1	1.8	12.4	1.7	1.0	1.9	5.2	11.8	1.1	1.3	3.5	12.4	1.7	7.8	0.0	0.9	2.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.5	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	15.4	3.7	0.0	1.1	2.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	33.4	15.9	14.5	13.0	14.3	17.1	9.1	20.5	12.4
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464278-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 24.9;BJ hTERT+: 25.9;fHDF/TERT166: 31.2;HSkMC: 20.0;LHCN-M2: 30.2;U-138 MG: 37.2"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol				Nucleoplasm	"Midbody, Cytosol"	"HPA049254: "	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.6	4.4	4.7	7.0	4.9	0.9	11.3	21.1	7.6	20.3	5.2	2.2	1.8	2.9	15.7	4.6	4.1	5.8	8.2	16.9	4.7	3.8	3.6	1.5	10.0	3.1	2.3	4.9	6.9	2.4	1.8	2.5	12.8	9.6	10.9	6.7	1.4	3.2	3.9	30.4	4.4	4.9	11.6	3.0	4.3	4.3	3.2	1.6	0.0	4.9	14.2	1.8	8.7	23.2	0.5	1.4	0.7	3.2	0.2	0.2	1.0	1.1	0.0	2.5	0.0	7.1	24.9	0.0	11.2	25.9	16.2	12.4	0.0	0.0	0.0	0.0	31.2	0.0	2.5	0.2	17.0	0.0	0.6	0.0	0.3	0.0	6.8	0.0	0.0	20.0	2.8	4.8	15.2	0.5	0.0	0.0	30.2	0.0	0.0	0.0	0.2	0.4	0.0	1.9	0.0	1.3	0.0	0.0	5.0	0.0	0.0	0.3	0.0	0.0	0.1	37.2	4.3	1.2	5.8	0.1	0.0	0.0	2.1	0.0	1.2	0.5	3.2	0.2	0.1	1.8	0.1	0.2	0.1	0.0	1.4	0.5	0.1	0.2	0.7	0.2	1.1	0.5	0.1	1.0	4.7	4.9	21.1	7.6	4.7	3.8	2.3	4.9	9.6	1.6
RCOR2		ENSG00000167771	"REST corepressor 2"	Q8IZ40	11	63911221-63916844	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.6"	"Cell line enhanced"	"Detected in some"		"AF22: 17.7;NTERA-2: 22.8;SCLC-21H: 35.8;SH-SY5Y: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021638	Uncertain		Approved	Nucleoplasm,Vesicles,Midbody				Nucleoplasm	"Vesicles, Midbody"	"HPA021638: AB_10960885"	"unprognostic (1.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.10e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.33e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.06e-3)"	0.8	1.4	3.3	0.7	8.0	0.3	0.7	9.3	16.6	3.0	1.4	3.4	0.0	2.0	3.5	2.6	1.2	3.7	1.6	5.9	4.0	2.6	0.7	0.4	1.0	0.3	2.4	3.8	5.2	1.4	3.2	5.0	1.8	1.8	1.7	1.7	3.3	2.3	1.7	3.1	0.6	1.6	2.5	2.2	0.5	1.2	7.0	2.5	4.1	0.6	0.6	0.3	2.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	17.7	1.2	0.2	1.5	5.3	0.1	0.3	0.2	0.6	0.6	0.1	0.1	0.2	0.4	0.2	7.7	0.0	0.2	0.2	0.9	0.2	0.1	5.6	3.0	0.0	0.1	1.8	0.0	0.3	0.0	0.1	0.9	0.0	0.0	1.5	1.6	6.2	22.8	0.0	5.7	1.0	0.5	0.0	0.0	35.8	23.9	0.1	1.6	0.8	1.3	2.1	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	8.0	9.3	11.0	4.0	2.6	2.4	3.8	1.8	2.5
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529629	"Enzymes, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071190			Approved	"Nucleoplasm,Golgi apparatus,Midbody"				"Nucleoplasm, Golgi apparatus"	Midbody	"HPA071190: "	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	21.6	22.0	23.5	18.9	26.2	30.1	23.5	10.8	30.5	14.3	16.3	17.2	30.8	16.3	11.5	12.9	16.0	12.9	12.1	11.4	27.0	31.8	27.9	32.4	16.9	24.3	30.6	20.3	12.1	11.8	25.0	12.5	16.5	33.4	14.7	17.4	14.1	15.9	22.9	30.6	11.5	21.8	9.6	20.5	21.3	16.8	10.4	14.1	23.0	17.1	11.7	24.1	16.1	12.8	5.7	4.3	4.5	9.2	5.9	8.5	4.0	20.8	9.8	5.1	12.5	14.7	11.6	11.6	27.7	15.1	22.7	16.3	6.3	13.1	17.1	24.2	20.6	12.1	9.8	15.2	36.6	23.4	7.1	16.9	12.2	5.7	11.3	24.6	19.8	11.9	16.2	22.3	21.4	13.0	14.7	23.8	38.9	8.8	13.0	6.5	6.8	13.3	8.4	22.9	14.2	15.1	21.6	9.3	8.6	24.4	22.7	17.8	19.6	27.6	20.2	26.0	14.7	17.9	38.5	24.7	34.2	20.2	21.6	12.1	23.4	4.5	3.3	3.7	8.2	8.6	8.5	5.4	6.2	6.8	3.6	5.7	6.3	7.1	2.0	5.9	9.2	4.3	4.9	4.0	23.5	26.2	10.8	30.5	27.0	31.8	30.6	20.3	33.4	14.1